D-0391-2021 Class III Terminated
FDA drug recall D-0391-2021 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on May 7, 2021 and is designated Class III. Reason for recall: Subpotent and Presence of Particulates . The recall status is terminated (terminated Jun 17, 2022).
Recall details
- Product Type
- Drugs
- Report Date
- May 26, 2021
- Initiation Date
- May 7, 2021
- Termination Date
- Jun 17, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-506-96
Reason for recall
Subpotent and Presence of Particulates .
Distribution pattern
Nationwide in the US
Code information
Lot # 10009, exp. date 03/2022 10006, exp. date 01/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0391-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026